{"id":"https://openalex.org/W2590287555","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.7536","title":"Drug pathway\u2013associated gene polymorphisms in patients with advanced non-small cell lung cancer receiving first-line platinum-gemcitabine combination chemotherapy: A prospective multicenter observational study.","display_name":"Drug pathway\u2013associated gene polymorphisms in patients with advanced non-small cell lung cancer receiving first-line platinum-gemcitabine combination chemotherapy: A prospective multicenter observational study.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2590287555","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.7536","mag":"2590287555"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.7536","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.7536","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.7536","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022167252","display_name":"Markus Joerger","orcid":"https://orcid.org/0000-0001-6602-6287","observed_orcids":["https://orcid.org/0000-0001-6602-6287"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Joerger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049408454","display_name":"Sjaak A. Burgers","orcid":"https://orcid.org/0000-0002-0218-8436","observed_orcids":["https://orcid.org/0000-0002-0218-8436"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. A. Burgers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"P. Baas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Baas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016904876","display_name":"Egbert Frederik Smit","orcid":"https://orcid.org/0000-0002-7329-6995","observed_orcids":["https://orcid.org/0000-0002-7329-6995"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. F. Smit","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025803452","display_name":"Tjeerd J. Haitjema","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. J. Haitjema","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M. P. L. Bard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. P. L. Bard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003864388","display_name":"Valerie D. Doodeman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. D. Doodeman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045762300","display_name":"Paul H.M. Smits","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. H. M. Smits","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113210253","display_name":"Alain Vincent","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Vincent","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010531755","display_name":"Alwin D. R. Huitema","orcid":"https://orcid.org/0000-0003-1939-4639","observed_orcids":["https://orcid.org/0000-0003-1939-4639"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Huitema","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. H. Beijnen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000418012","display_name":"Jan H.M. Schellens","orcid":"https://orcid.org/0000-0001-6832-1976","observed_orcids":["https://orcid.org/0000-0001-6832-1976"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. H. M. Schellens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"7536","last_page":"7536"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9003999829292297,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9003999829292297,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.08720000088214874,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.847000002861023},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ercc1","display_name":"ERCC1","score":0.8230000138282776},{"id":"https://openalex.org/keywords/gstp1","display_name":"GSTP1","score":0.8209999799728394},{"id":"https://openalex.org/keywords/ercc2","display_name":"XPD","score":0.8109999895095825},{"id":"https://openalex.org/keywords/xrcc1","display_name":"XRCC1","score":0.9940000176429749},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7960000038146973},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8999999761581421},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8180000185966492},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6690000295639038},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.6380000114440918},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5540000200271606},{"id":"https://openalex.org/keywords/germline-mutations","display_name":"germline mutations","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8105142116546631},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7969387769699097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7549827098846436},{"id":"https://openalex.org/C2779309665","wikidata":"https://www.wikidata.org/wiki/Q17917256","display_name":"ERCC1","level":5,"score":0.6656568050384521},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6567169427871704},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6301143169403076},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6034921407699585},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5700672268867493},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.5403634905815125},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4248703122138977},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4230092167854309},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4122992753982544},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.14555802941322327},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.0802437961101532},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07837381958961487},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06345739960670471},{"id":"https://openalex.org/C104451858","wikidata":"https://www.wikidata.org/wiki/Q2714458","display_name":"Nucleotide excision repair","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.7536","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.7536","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.7536","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1530173448","https://openalex.org/W2148725710","https://openalex.org/W2552994841","https://openalex.org/W2767230648","https://openalex.org/W2167676866","https://openalex.org/W4300467397","https://openalex.org/W2036457894","https://openalex.org/W2735708159","https://openalex.org/W2388910386","https://openalex.org/W2965245109"],"abstract_inverted_index":{"7536":[0],"Background:":[1],"We":[2],"assessed":[3],"the":[4,90,95,106,114,125,172,177,198,201,205],"impact":[5],"of":[6,41,94,105,113,124,176,197,215],"gene":[7],"polymorphisms":[8,183],"on":[9],"clinical":[10],"outcome":[11],"in":[12,36,39,46,184,195],"advanced":[13,187],"non-small":[14],"cell":[15],"lung":[16],"cancer":[17],"(NSCLC)":[18],"patients":[19,26,82,185],"receiving":[20,31,189],"platinum-gemcitabine":[21],"chemotherapy":[22,34,194],"(PG).":[23],"Methods:":[24],"137":[25],"with":[27,58,136,166,186],"stage":[28],"IIIB/IV":[29],"NSCLC":[30,188],"first-line":[32],"PG":[33],"(cisplatin":[35],"74%,":[37],"carboplatin":[38],"26%":[40],"patients)":[42],"were":[43,49,56,163],"included.":[44],"Mutations":[45],"15":[47],"genes":[48],"analyzed":[50],"from":[51],"peripheral":[52],"blood,":[53],"and":[54,69,155,180,204,211],"genotypes":[55],"compared":[57,102,121],"progression-free":[59,221],"survival":[60,67,224],"(PFS),":[61],"objective":[62],"response":[63],"rate":[64],"(ORR),":[65],"overall":[66],"(OS)":[68],"toxicity.":[70],"Results:":[71],"Median":[72],"PFS":[73,101],"was":[74,134],"5.8":[75],"months,":[76],"median":[77],"OS":[78],"10.2":[79],"months;":[80],"44":[81],"(32%)":[83],"had":[84,98,117],"a":[85,99,118],"partial":[86],"treatment":[87],"response.":[88],"In":[89],"adjusted":[91],"model,":[92],"carriers":[93,104,123,196],"ERCC1":[96,115,141,199,235],"T-allele":[97,126],"lower":[100],"to":[103,122],"CC-genotype":[107,116,238],"(HR":[108,142,149,157],"1.62,":[109],"95%,":[110],"p=0.05).":[111],"Carriers":[112],"higher":[119],"ORR":[120],"(52%":[127],"vs.":[128],"29%,":[129],"p=0.02).":[130],"The":[131],"GSTP1":[132],"GG-genotype":[133,253],"associated":[135,165],"severe":[137],"platinum-associated":[138],"polyneuropathy":[139],"(p=0.01).":[140],"1.54,":[143],"95%":[144,151,159,231],"CI":[145,152,160,232],"1.00-2.39,":[146],"p=0.05),":[147],"XPD10":[148,181,206,250],"0.64,":[150],"0.42-0.98,":[153],"p=0.04)":[154],"XRCC1":[156,179,202],"0.51,":[158],"0.29-0.91,":[161],"p=0.02)":[162],"independently":[164],"OS.":[167],"Conclusions:":[168],"This":[169],"study":[170],"supports":[171],"potential":[173],"predictive":[174],"value":[175],"ERCC1,":[178],"germline":[182],"platinum-based":[190],"chemotherapy.":[191],"Non":[192],"platinum-containing":[193],"T-allele,":[200],"A-allele":[203],"G-allele":[207],"may":[208],"be":[209,213],"considered":[210],"could":[212],"subject":[214],"further":[216],"studies.":[217],"Multivariate":[218],"model":[219],"for":[220],"survival.":[222],"Progression-free":[223],"Parameter":[225],"or":[226,243,258,283],"genotype":[227],"Patients":[228],"%":[229],"HR":[230],"Log-rank":[233],"P":[234],"codon":[236,251],"118":[237],"25":[239],"18":[240],"Ref.":[241,256,269,281],"CT":[242],"TT":[244],"112":[245],"82":[246,285],"1.62":[247],"1.01-2.61":[248],"0.05":[249],"312":[252],"53":[254],"39":[255],"GA":[257],"AA":[259],"84":[260],"61":[261],"0.92":[262],"0.63-1.34":[263],"0.66":[264],"Stage":[265],"IIIB":[266],"42":[267],"31":[268],"IV":[270],"95":[271],"69":[272],"0.81":[273],"0.55-1.18":[274],"0.27":[275],"ECOG":[276],"PS":[277],"0":[278],"52":[279],"38":[280],"1":[282],"2":[284],"62":[286],"1.52":[287],"1.05-2.19":[288],"0.03":[289],"Smoking":[290],"habit":[291],"Never-smoker":[292],"23":[293],"17":[294],"Ref":[295],"Ever-smoker":[296],"114":[297],"83":[298],"2.28":[299],"1.40-3.71":[300],"<0.01":[301]},"counts_by_year":[],"updated_date":"2026-10-11T09:32:39.932853","created_date":"2017-03-03T00:00:00"}